CPAP

GLP-1 weight-loss drugs such as Ozempic and Wegovy are being linked to changes in sleep health, with researchers examining how significant weight loss affects sleep apnoea and other sleep disorders. The trend is prompting sleep medicine specialists to rethink diagnosis rates, treatment demand and how therapies like CPAP may be used as more patients take these medications.

A newly published case report in Cureus describes a patient who developed lesser occipital neuralgia attributed to the headgear of a CPAP mask used for sleep apnea treatment. The report suggests that prolonged pressure from mask straps on the nerves at the back of the head may cause chronic headache and scalp pain, raising awareness of a rare side effect among sleep medicine providers.

CPAP Medical Supplies and Services has agreed to pay up to $500,000 to settle a class action lawsuit over a data breach affecting its customers. The settlement resolves claims that the company failed to adequately protect patients' personal and health information, in a case tracked closely by healthcare privacy observers.